Disease management--constructing optimal NRTI-based combinations: past, present, and future.
Dieterich
Douglas T
DT
Department of Medicine, The Mount Sinai Medical Center, New York, NY, USA. douglas.dieterich@msnyuhealth.org
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000639:trends; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D005544:Forecasting; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D044966:Anti-Retroviral Agents; D018894:Reverse Transcriptase Inhibitors